Skip to main content

Cancer Moonshot℠ - Funding by Research Category

To ensure the Cancer Moonshot goals and approaches were grounded in the best science, NCI convened a Blue Ribbon Panel (BRP) of scientific experts as a working group to the National Cancer Advisory board. In September of 2016, the BRP presented a final report outlining 10 research recommendations that represent areas that are well-positioned to accelerate progress in cancer prevention, diagnosis, treatment and care.

Download the Data

The following research categories align with these 10 recommendations:

Cancer Moonshot by Category, FY 2021
(Whole Dollars)
Research Category Amount1
Network for Direct Patient Engagement     $53,968,535
Cancer Immunotherapy Translational Science Network    

$41,061,992

Therapeutic Target Identification to Overcome Drug Resistance    

$12,369,888

A National Cancer Data Ecosystem for Sharing and Analysis    

$10,646,973

Fusion Oncoproteins in Childhood Cancers    

$1,172,420

Minimize Cancer Treatment’s Debilitating Side Effects

$8,179,143

Prevention and early detection: Implementation of Evidence-Based Approaches

$41,263,844

Retrospective Analysis of Biospecimens form Patients Treated with Standard of Care

$96

Generation of Human Tumor Atlases

$15,770,950

Development of New Enabling Cancer Technologies

$21,785,549

Other Cancer Moonshot priority activities (e.g., Partnership for Accelerating Cancer Therapies)

$16,400

Total $206,235,789

1 Includes new obligations and recoveries from fiscal years 2017, 2018, 2019 and 2020 carryover accounts.  

 

  • Posted: